Literature DB >> 28916232

Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin.

Mohan S Maddur1, Srini V Kaveri2, Jagadeesh Bayry3.   

Abstract

Intravenous immunoglobulin (IVIG), a pooled normal IgG formulation prepared from thousands of healthy donors' plasma, is extensively used for the immunotherapy of autoimmune and inflammatory disorders. Recent reports demonstrate that IVIG exerts anti-inflammatory actions by stimulating the activation and expansion of regulatory T (Treg) cells by multiple mechanisms via antigen-presenting cells (APCs).
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DC-SIGN; DCIR; IL-33; antibody; dendritic cells; intravenous immunoglobulin; prostaglandin E2; regulatory T cells; tregitopes

Mesh：

Substances：

Year:  2017        PMID： 28916232     DOI： 10.1016/j.it.2017.08.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN： 1471-4906            Impact factor:   16.687


  18 in total

1.  Intravenous immunoglobulin suppresses the polarization of both classically and alternatively activated macrophages.

Authors:  Chaitrali Saha; Prathap Kothapalli; Veerupaxagouda Patil; Gundallahalli Bayyappa ManjunathaReddy; Srini V Kaveri; Jagadeesh Bayry
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

2.  Induction of human dendritic cell maturation by naïve and memory B-cell subsets requires different activation stimuli.

Authors:  Mohan S Maddur; Srini V Kaveri; Jagadeesh Bayry
Journal:  Cell Mol Immunol       Date:  2018-03-22       Impact factor: 11.530

Review 3.  Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis.

Authors:  Mohan S Maddur; Sébastien Lacroix-Desmazes; Jordan D Dimitrov; Michel D Kazatchkine; Jagadeesh Bayry; Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

4.  Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study.

Authors:  Ziyun Shao; Yongwen Feng; Li Zhong; Qifeng Xie; Ming Lei; Zheying Liu; Conglin Wang; Jingjing Ji; Huiheng Liu; Zhengtao Gu; Zhongwei Hu; Lei Su; Ming Wu; Zhifeng Liu
Journal:  Clin Transl Immunology       Date:  2020-10-14

5.  Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment.

Authors:  Leonard B Weinstock; Jill B Brook; Trisha L Myers; Brent Goodman
Journal:  BMJ Case Rep       Date:  2018-01-11

6.  IgG Fc Glycosylation Patterns of Preterm Infants Differ With Gestational Age.

Authors:  Nele Twisselmann; Yannic C Bartsch; Julia Pagel; Christian Wieg; Annika Hartz; Marc Ehlers; Christoph Härtel
Journal:  Front Immunol       Date:  2019-01-18       Impact factor: 7.561

7.  Therapeutic normal IgG intravenous immunoglobulin activates Wnt-β-catenin pathway in dendritic cells.

Authors:  Anupama Karnam; Naresh Rambabu; Mrinmoy Das; Melissa Bou-Jaoudeh; Sandrine Delignat; Fabian Käsermann; Sébastien Lacroix-Desmazes; Srini V Kaveri; Jagadeesh Bayry
Journal:  Commun Biol       Date:  2020-03-04

Review 8.  Modulation of Immune-Inflammatory Responses in Abdominal Aortic Aneurysm: Emerging Molecular Targets.

Authors:  Hanrong Li; Shuling Bai; Qiang Ao; Xiaohong Wang; Xiaohong Tian; Xiang Li; Hao Tong; Weijian Hou; Jun Fan
Journal:  J Immunol Res       Date:  2018-06-03       Impact factor: 4.818

9.  Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy.

Authors:  Mrinmoy Das; Anupama Karnam; Emmanuel Stephen-Victor; Laurent Gilardin; Bharat Bhatt; Varun Kumar Sharma; Naresh Rambabu; Veerupaxagouda Patil; Maxime Lecerf; Fabian Käsermann; Patrick Bruneval; Kithiganahalli Narayanaswamy Balaji; Olivier Benveniste; Srini V Kaveri; Jagadeesh Bayry
Journal:  Cell Death Dis       Date:  2020-01-23       Impact factor: 8.469

10.  Relationship between natural and infection-induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA.

Authors:  K Böröcz; D Simon; S Erdő-Bonyár; K T Kovács; É Tuba; L Czirják; P Németh; T Berki
Journal:  Clin Exp Immunol       Date:  2020-10-13       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.